Antiparkinsonian activity of selective MAO-B inhibitors of different chemical structures

Introduction: Parkinson’s disease (PD) is a chronic neurodegenerative disease of the central nervous system, the pathogenesis of which is associated with the death of dopaminergic neurons of the midbrain substantia nigra. The mainstay of therapy for PD is levodopa. However, in the initial stages of...

Full description

Saved in:
Bibliographic Details
Main Authors: Vladimir N. Fedorov, Mikhail K. Korsakov, Anton A. Shetnev, Sergey S. Petukhov, Nikita N. Volkhin, Vladimir P. Vdovichenko, Anastasia A. Khokhlova, Salavat Sh. Suleymanov
Format: Article
Language:English
Published: Belgorod National Research University 2024-12-01
Series:Research Results in Pharmacology
Subjects:
Online Access:https://rrpharmacology.ru/index.php/journal/article/view/540
Tags: Add Tag
No Tags, Be the first to tag this record!